Greenwich LifeSciences (GLSI) News Today $12.16 -0.71 (-5.52%) Closing price 04:00 PM EasternExtended Trading$12.38 +0.22 (+1.77%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Glancy Prongay & Murray LLP Announces Investigation of Greenwich LifeSciences, Inc. (GLSI)January 17, 2025 | businesswire.comGreenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01January 14, 2025 | globenewswire.comInsider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases 2,500 Shares of StockJanuary 14, 2025 | insidertrades.comGreenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into FranceJanuary 13, 2025 | markets.businessinsider.comInsider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Buys 2,500 Shares of StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 2,500 shares of the stock in a transaction dated Friday, January 10th. The shares were purchased at an average price of $12.51 per share, for a total transaction of $31,275.00. Following the completion of the purchase, the chief executive officer now directly owns 5,552,502 shares in the company, valued at $69,461,800.02. The trade was a 0.05 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.January 13, 2025 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Buys 1,800 SharesJanuary 9, 2025 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Acquires 1,800 SharesGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 1,800 shares of the company's stock in a transaction that occurred on Tuesday, January 7th. The stock was purchased at an average cost of $13.75 per share, for a total transaction of $24,750.00. Following the transaction, the chief executive officer now owns 5,550,002 shares in the company, valued at $76,312,527.50. The trade was a 0.03 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.January 8, 2025 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Acquires 2,000 SharesJanuary 7, 2025 | insidertrades.comSnehal Patel Buys 2,000 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 2,000 shares of Greenwich LifeSciences stock in a transaction on Thursday, January 2nd. The stock was acquired at an average price of $11.97 per share, for a total transaction of $23,940.00. Following the purchase, the chief executive officer now owns 5,543,702 shares of the company's stock, valued at approximately $66,358,112.94. This trade represents a 0.04 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.January 6, 2025 | marketbeat.comSnehal Patel Acquires 3,200 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockJanuary 3, 2025 | insidertrades.comSnehal Patel Buys 3,200 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 3,200 shares of Greenwich LifeSciences stock in a transaction that occurred on Monday, December 30th. The shares were purchased at an average cost of $11.12 per share, for a total transaction of $35,584.00. Following the purchase, the chief executive officer now directly owns 5,539,302 shares in the company, valued at $61,597,038.24. The trade was a 0.06 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.January 2, 2025 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Up 8.1% in DecemberGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 530,200 shares, a growth of 8.1% from the November 30th total of 490,400 shares. Approximately 9.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 28,200 shares, the short-interest ratio is presently 18.8 days.January 1, 2025 | marketbeat.comGreenwich LifeSciences Partners With Breast C...November 26, 2024 | benzinga.comGreenwich LifeSciences Partners with GIM in ItalyNovember 26, 2024 | globenewswire.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) VP Buys $12,910.00 in StockNovember 26, 2024 | insidertrades.comJaye Thompson Acquires 1,000 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) VP Jaye Thompson purchased 1,000 shares of the business's stock in a transaction that occurred on Thursday, November 21st. The shares were purchased at an average price of $12.91 per share, for a total transaction of $12,910.00. Following the completion of the acquisition, the vice president now directly owns 264,148 shares in the company, valued at $3,410,150.68. The trade was a 0.38 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.November 25, 2024 | marketbeat.comGreenwich LifeSciences Provides Update on Corporate EventsNovember 18, 2024 | globenewswire.comGreenwich LifeSciences (NASDAQ:GLSI) Stock Price Down 1.6% - Time to Sell?Greenwich LifeSciences (NASDAQ:GLSI) Trading Down 1.6% - Should You Sell?November 14, 2024 | marketbeat.comGreenwich LifeSciences (NASDAQ:GLSI) Stock Price Up 3.1% - Still a Buy?Greenwich LifeSciences (NASDAQ:GLSI) Stock Price Up 3.1% - Still a Buy?October 23, 2024 | marketbeat.comGreenwich LifeSciences (NASDAQ:GLSI) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comInsider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases 1,500 Shares of StockOctober 1, 2024 | insidertrades.comSnehal Patel Acquires 1,500 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel purchased 1,500 shares of the firm's stock in a transaction on Thursday, September 26th. The stock was acquired at an average price of $14.63 per share, for a total transaction of $21,945.00. Following the completion of the transaction, the chief executive officer now directly owns 5,536,102 shares of the company's stock, valued at approximately $80,993,172.26. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.September 30, 2024 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) VP Jaye Thompson Buys 800 SharesSeptember 17, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders seem bullish, own 55% and have been buying more recentlySeptember 12, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$3.36m On Greenwich LifeSciencesAugust 17, 2024 | uk.finance.yahoo.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases $72,490.00 in StockAugust 8, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Purchases 5,500 SharesGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 5,500 shares of the stock in a transaction on Monday, August 5th. The shares were acquired at an average cost of $13.18 per share, with a total value of $72,490.00. Following the acquisition, the chief executive officer now directly owns 5,532,602 shares in the company, valued at approximately $72,919,694.36. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.August 7, 2024 | marketbeat.comJaye Thompson Purchases 1,000 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockAugust 6, 2024 | insidertrades.comGreenwich Lifesciences Inc (GLSI)August 4, 2024 | investing.comGreenwich LifeSciences Provides Update on Expansion of Flamingo-01 into SpainAugust 1, 2024 | globenewswire.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires $23,835.00 in StockJuly 25, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Buys $23,835.00 in StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel purchased 1,500 shares of the business's stock in a transaction that occurred on Tuesday, July 23rd. The shares were purchased at an average price of $15.89 per share, for a total transaction of $23,835.00. Following the completion of the acquisition, the chief executive officer now owns 5,527,102 shares of the company's stock, valued at approximately $87,825,650.78. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.July 24, 2024 | marketbeat.comInsider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) VP Acquires 1,000 Shares of StockJuly 23, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) VP Jaye Thompson Buys 1,000 SharesGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) VP Jaye Thompson purchased 1,000 shares of the company's stock in a transaction that occurred on Thursday, July 18th. The shares were acquired at an average cost of $16.00 per share, for a total transaction of $16,000.00. Following the completion of the transaction, the vice president now directly owns 261,348 shares of the company's stock, valued at approximately $4,181,568. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.July 22, 2024 | marketbeat.comGreenwich LifeSciences Set to Join Russell 2000 Index AgainJune 26, 2024 | globenewswire.comSnehal Patel Acquires 174,825 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockJune 18, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires $2,499,997.50 in StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 174,825 shares of Greenwich LifeSciences stock in a transaction dated Thursday, June 13th. The stock was bought at an average price of $14.30 per share, for a total transaction of $2,499,997.50. Following the completion of the purchase, the chief executive officer now owns 5,525,602 shares of the company's stock, valued at approximately $79,016,108.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.June 17, 2024 | marketbeat.comGreenwich LifeSciences Announces $2.5 Million Private PlacementJune 14, 2024 | globenewswire.comGreenwich LifeSciences, Inc. (GLSI)May 26, 2024 | finance.yahoo.comHC Wainwright Brokers Lift Earnings Estimates for Greenwich LifeSciences, Inc. (NASDAQ:GLSI)Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Research analysts at HC Wainwright boosted their FY2024 earnings per share (EPS) estimates for Greenwich LifeSciences in a report issued on Wednesday, May 22nd. HC Wainwright analyst Y. Chen now anticipates that the company will post earnMay 24, 2024 | marketbeat.comGreenwich LifeSciences, Inc. Expected to Earn Q1 2025 Earnings of ($0.17) Per Share (NASDAQ:GLSI)Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Equities researchers at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Greenwich LifeSciences in a research note issued to investors on Wednesday, May 22nd. HC Wainwright analyst Y. Chen forecasts thatMay 23, 2024 | marketbeat.comGreenwich LifeSciences (NASDAQ:GLSI) Receives Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $36.00 target price on shares of Greenwich LifeSciences in a research report on Wednesday.May 22, 2024 | marketbeat.comGLSI Stock Earnings: Greenwich LifeSciences Beats EPS for Q1 2024May 20, 2024 | investorplace.comGLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023April 15, 2024 | markets.businessinsider.comSnehal Patel Buys 3,000 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockApril 4, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases $57,240.00 in StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 3,000 shares of the business's stock in a transaction that occurred on Monday, April 1st. The shares were acquired at an average cost of $19.08 per share, with a total value of $57,240.00. Following the completion of the transaction, the chief executive officer now directly owns 5,350,777 shares in the company, valued at approximately $102,092,825.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.April 3, 2024 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Acquires 2,500 SharesMarch 27, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires $49,950.00 in StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 2,500 shares of the stock in a transaction on Friday, March 22nd. The stock was acquired at an average price of $19.98 per share, with a total value of $49,950.00. Following the completion of the acquisition, the chief executive officer now owns 5,347,777 shares of the company's stock, valued at approximately $106,848,584.46. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.March 26, 2024 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Purchases 1,500 SharesMarch 23, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Acquires 4,100 SharesMarch 16, 2024 | insidertrades.com Get Greenwich LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address GLSI Media Mentions By Week GLSI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLSI News Sentiment▼0.800.57▲Average Medical News Sentiment GLSI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLSI Articles This Week▼11▲GLSI Articles Average Week Get Greenwich LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ORIC News Today ETNB News Today EOLS News Today BCAX News Today IMTX News Today IMNM News Today DNA News Today LENZ News Today ABUS News Today TECX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GLSI) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenwich LifeSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenwich LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLSI Stock Alerts